Literature DB >> 20083606

Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors.

Guo-Dong Li1, David C Chiara, Jonathan B Cohen, Richard W Olsen.   

Abstract

Enhancement of gamma-aminobutyric acid type A receptor (GABA(A)R)-mediated inhibition is a property of most general anesthetics and a candidate for a molecular mechanism of anesthesia. Intravenous anesthetics, including etomidate, propofol, barbiturates, and neuroactive steroids, as well as volatile anesthetics and long-chain alcohols, all enhance GABA(A)R function at anesthetic concentrations. The implied existence of a receptor site for anesthetics on the GABA(A)R protein was supported by identification, using photoaffinity labeling, of a binding site for etomidate within the GABA(A)R transmembrane domain at the beta-alpha subunit interface; the etomidate analog [(3)H]azietomidate photolabeled in a pharmacologically specific manner two amino acids, alpha1Met-236 in the M1 helix and betaMet-286 in the M3 helix (Li, G. D., Chiara, D. C., Sawyer, G. W., Husain, S. S., Olsen, R. W., and Cohen, J. B. (2006) J. Neurosci. 26, 11599-11605). Here, we use [(3)H]azietomidate photolabeling of bovine brain GABA(A)Rs to determine whether other structural classes of anesthetics interact with the etomidate binding site. Photolabeling was inhibited by anesthetic concentrations of propofol, barbiturates, and the volatile agent isoflurane, at low millimolar concentrations, but not by octanol or ethanol. Inhibition by barbiturates, which was pharmacologically specific and stereospecific, and by propofol was only partial, consistent with allosteric interactions, whereas isoflurane inhibition was nearly complete, apparently competitive. Protein sequencing showed that propofol inhibited to the same extent the photolabeling of alpha1Met-236 and betaMet-286. These results indicate that several classes of general anesthetics modulate etomidate binding to the GABA(A)R: isoflurane binds directly to the site with millimolar affinity, whereas propofol and barbiturates inhibit binding but do not bind in a mutually exclusive manner with etomidate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083606      PMCID: PMC2838283          DOI: 10.1074/jbc.M109.074708

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Molecular and neuronal substrates for general anaesthetics.

Authors:  Uwe Rudolph; Bernd Antkowiak
Journal:  Nat Rev Neurosci       Date:  2004-09       Impact factor: 34.870

2.  Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors.

Authors:  S J Mihic; Q Ye; M J Wick; V V Koltchine; M D Krasowski; S E Finn; M P Mascia; C F Valenzuela; K K Hanson; E P Greenblatt; R A Harris; N L Harrison
Journal:  Nature       Date:  1997-09-25       Impact factor: 49.962

3.  Interaction of barbiturates with dihydropicrotoxinin binding sites related to the GABA receptor-ionophore system.

Authors:  M K Ticku; R W Olsen
Journal:  Life Sci       Date:  1978-05-08       Impact factor: 5.037

4.  Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor.

Authors:  C Hill-Venning; D Belelli; J A Peters; J J Lambert
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

5.  Interactions of barbiturates of various pharmacological categories with benzodiazepine receptors.

Authors:  F Leeb-Lundberg; R W Olsen
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

6.  Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane.

Authors:  M D Krasowski; V V Koltchine; C E Rick; Q Ye; S E Finn; N L Harrison
Journal:  Mol Pharmacol       Date:  1998-03       Impact factor: 4.436

7.  Trichloroethanol modulation of recombinant GABAA, glycine and GABA rho 1 receptors.

Authors:  M D Krasowski; S E Finn; Q Ye; N L Harrison
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

8.  The effects of isoflurane on desensitized wild-type and alpha 1(S270H) gamma-aminobutyric acid type A receptors.

Authors:  Adam C Hall; Kathleen C Rowan; Renna J N Stevens; Jill C Kelley; Neil L Harrison
Journal:  Anesth Analg       Date:  2004-05       Impact factor: 5.108

9.  Defining the propofol binding site location on the GABAA receptor.

Authors:  Moez Bali; Myles H Akabas
Journal:  Mol Pharmacol       Date:  2004-01       Impact factor: 4.436

10.  Barbiturates allosterically inhibit GABA antagonist and benzodiazepine inverse agonist binding.

Authors:  E H Wong; A M Snowman; L M Leeb-Lundberg; R W Olsen
Journal:  Eur J Pharmacol       Date:  1984-07-13       Impact factor: 4.432

View more
  48 in total

Review 1.  A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.

Authors:  Werner Sieghart; Joachim Ramerstorfer; Isabella Sarto-Jackson; Zdravko Varagic; Margot Ernst
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.

Authors:  Pavel Y Savechenkov; Xi Zhang; David C Chiara; Deirdre S Stewart; Rile Ge; Xiaojuan Zhou; Douglas E Raines; Jonathan B Cohen; Stuart A Forman; Keith W Miller; Karol S Bruzik
Journal:  J Med Chem       Date:  2012-07-17       Impact factor: 7.446

3.  A Cysteine Substitution Probes β3H267 Interactions with Propofol and Other Potent Anesthetics in α1β3γ2L γ-Aminobutyric Acid Type A Receptors.

Authors:  Alex T Stern; Stuart A Forman
Journal:  Anesthesiology       Date:  2016-01       Impact factor: 7.892

4.  Atomistic insights into human Cys-loop receptors by solution NMR.

Authors:  David D Mowrey; Monica N Kinde; Yan Xu; Pei Tang
Journal:  Biochim Biophys Acta       Date:  2014-03-28

5.  Multiple transmembrane binding sites for p-trifluoromethyldiazirinyl-etomidate, a photoreactive Torpedo nicotinic acetylcholine receptor allosteric inhibitor.

Authors:  Ayman K Hamouda; Deirdre S Stewart; S Shaukat Husain; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

Review 6.  The concept of allosteric interaction and its consequences for the chemistry of the brain.

Authors:  Jean-Pierre Changeux
Journal:  J Biol Chem       Date:  2013-07-22       Impact factor: 5.157

Review 7.  Structural models of ligand-gated ion channels: sites of action for anesthetics and ethanol.

Authors:  Richard W Olsen; Guo-Dong Li; Martin Wallner; James R Trudell; Edward J Bertaccini; Erik Lindahl; Keith W Miller; Ronald L Alkana; Daryl L Davies
Journal:  Alcohol Clin Exp Res       Date:  2013-10-24       Impact factor: 3.455

Review 8.  50 years of allosteric interactions: the twists and turns of the models.

Authors:  Jean-Pierre Changeux
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10-23       Impact factor: 94.444

9.  Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site.

Authors:  Anahita Nourmahnad; Alex T Stern; Mayo Hotta; Deirdre S Stewart; Alexis M Ziemba; Andrea Szabo; Stuart A Forman
Journal:  Anesthesiology       Date:  2016-12       Impact factor: 7.892

10.  State-dependent etomidate occupancy of its allosteric agonist sites measured in a cysteine-substituted GABAA receptor.

Authors:  Deirdre S Stewart; Mayo Hotta; Rooma Desai; Stuart A Forman
Journal:  Mol Pharmacol       Date:  2013-03-22       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.